1 completed. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow Placebo-AG019: new trials by email Literature Review of Placebo-AG019 trials Research Report on Placebo-AG019
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Assess the Safety and Tolerability of Different Doses of AG019 Administered Alone or in Combination With Teplizumab in Participants With Recent-onset Diagnosed Type 1 Diabetes (T1D) AG019 - Low Dose, Teplizumab, Placebo-AG019 - Diabetes type1 | Phase 1 / Phase 2 | Completed | Precigen Actobio T1D, LLC | 45 | 2018-10-24 | 2023-02-01 |
Belgium (1) · United States (1)
Chantal Mathieu, MD (1) · Kevan Herold, MD (1)
2017 (1)